Corticotropin-releasing factor receptor antagonism within the dorsal raphe nucleus reduces social anxiety-like behavior after early-life social isolation.
Social isolation of rats during the early part of development increases social anxiety-like behavior in adulthood. Furthermore, early-life social isolation increases the levels of corticotropin-releasing factor (CRF) receptors in the serotonergic dorsal raphe nucleus (dRN) of adult rats. Interactions between serotonin and CRF systems are thought to mediate anxiety behavior. Therefore, we investigated the effects of CRF receptor antagonism within the dRN on social anxiety-like behavior after early-life social isolation. Male rats were reared in isolation or in groups from weaning until midadolescence, and rehoused in groups and allowed to develop into adulthood. Adult rats underwent surgery to implant a drug cannula into the dRN. After recovery from surgery and acclimation to the testing arena, rats were infused with vehicle or the CRF receptor antagonist d-Phe-CRF((12-41)) (50 or 500 ng) into the dRN before a social interaction test. Isolation-reared rats pretreated with vehicle exhibited increased social anxiety-like behavior compared with rats reared in groups. Pretreatment of the dRN with d-Phe-CRF((12-41)) significantly reduced social anxiety-like behaviors exhibited by isolation-reared rats. Overall, this study shows that early-life social stress results in heightened social anxiety-like behavior, which is reversed by CRF antagonism within the dRN. These data suggest that CRF receptor antagonists could provide a potential treatment of stress-related social anxiety.
Lukkes
Jodi
J
University of South Dakota, Vermillion, 57069, USA.
Vuong
Shawn
S
Scholl
Jamie
J
Oliver
Harvey
H
Forster
Gina
G
D000704:Analysis of Variance; D000818:Animals; D001007:Anxiety / Q000188:drug therapy*; D002404:Catheterization; D003346:Corticotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000494:pharmacology; D008124:Locomotion / Q000187:drug effects; D008297:Male; D011903:Raphe Nuclei / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D012919:Social Behavior; D012934:Social Isolation; D013997:Time Factors
D018019:Receptors, Corticotropin-Releasing Hormone; C113202:phenylalanyl corticotropin-releasing factor (12-41); D003346:Corticotropin-Releasing Hormone
Eur J Pharmacol. 2008 Jan 14;578(2-3):185-93
17945210
Neuropsychopharmacology. 2000 Mar;22(3):230-9
10693150
Brain Res. 1996 Sep 2;732(1-2):145-53
8891278
Behav Neurosci. 1989 Jun;103(3):648-54
2786722
Horm Behav. 1987 Jun;21(2):193-202
2886414
Psychopharmacology (Berl). 2007 Oct;194(3):297-307
17581742
Horm Behav. 2005 Jun;48(1):1-10
15919381
J Neurosci Methods. 1980 Dec;3(2):129-49
6110810
Neuroscience. 2007 Jun 8;146(4):1888-905
17467184
J Neurosci. 1995 Oct;15(10):6340-50
7472399
J Neurosci. 2006 Sep 6;26(36):9142-52
16957071
J Neurosci. 2004 Feb 11;24(6):1305-11
14960601
Neuroscience. 2009 Jan 23;158(2):845-55
19010398
Crit Rev Neurobiol. 1998;12(1-2):129-62
9444483
Psychopharmacol Bull. 2004 Winter;38(1):14-20
15278013
Neuroscience. 2006 Aug 25;141(2):1047-1055
16713119
J Pharmacol Exp Ther. 1999 Feb;288(2):729-34
9918582
J Neurosci. 1999 Oct 15;19(20):RC35
10516337
Horm Behav. 2009 Jan;55(1):248-56
19027017
Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):3-18
12732219
Eur J Pharmacol. 2005 Feb 21;509(2-3):145-53
15733549
Brain Res. 1992 May 29;581(2):190-7
1327398
Brain Res. 2001 Jun 1;902(2):135-42
11384606
J Pharmacol Exp Ther. 2002 Jul;302(1):145-52
12065711
Stress. 2005 Dec;8(4):233-46
16423712
J Neurosci. 2001 Apr 15;21(8):2833-41
11306635
J Pharmacol Exp Ther. 1999 May;289(2):926-35
10215672
Neuroscience. 2006;138(4):1265-76
16488545
Neuroscience. 2004;129(3):509-19
15541873
Horm Behav. 2001 May;39(3):195-205
11300710
Dev Psychobiol. 1999 Mar;34(2):129-38
10086231